Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yahya B Juwana

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Invasive Cardiology|July 7, 2010
Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysisYahya B Juwana, Saman Rasoul, Jan Paul Ottervanger, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Tirofiban for myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|July 7, 2009
Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Invasive Cardiology|July 7, 2010
Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysisYahya B Juwana, Saman Rasoul, Jan Paul Ottervanger, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Tirofiban for myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
The American Journal of Cardiology|July 7, 2009
Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionYahya B Juwana, Harry Suryapranata, Jan Paul Ottervanger, et al.
Pageof 1